Iron deficiency and anaemia in bariatric surgical patients: Causes, diagnosis and proper management

Nutricion Hospitalaria

Volumn 24, Issue 6, 2009, Pages 640-654

  Muñoz, Manuel ^a   Botella Romero, F ^b   Gomez Ramirez S ^c   Campos, A ^c   Garcia Erce J A ^d  

^a UNIVERSITY OF MÁLAGA   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE ALBACETE   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^d HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

Author keywords

Anaemia; Bariatric surgery; Inflammation; Iron deficiency; Morbid obesity

Indexed keywords

ADIPOKINES; ADMINISTRATION, ORAL; ANEMIA, IRON-DEFICIENCY; BARIATRIC SURGERY; DRUG RESISTANCE; FEMALE; FERRIC COMPOUNDS; GASTROINTESTINAL HEMORRHAGE; HUMANS; INFLAMMATION; INFUSIONS, INTRAVENOUS; INTESTINAL ABSORPTION; IRON; MALABSORPTION SYNDROMES; MALTOSE; MIDDLE AGED; OBESITY; PEPTIC ULCER HEMORRHAGE; POSTGASTRECTOMY SYNDROMES; PRACTICE GUIDELINES AS TOPIC; PREOPERATIVE CARE;

EID: 73249138562     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: 10.3305/nh.2009.24.6.4547     Document Type: Review

References (85)

1. Berghöfer A, Pischon T, Reinhold T, Apovian CM, Sharma AM, Willich SN. Obesity prevalence from a European perspective: a systematic review. BMC Public Health 2008; 8: 200.
2. Muñoz M, Mazure RA, Culebras JM. Obesidad y sistema inmune. Nutr Hosp 2004; 19: 319-24.
3. Yanoff LB, Menzie CM, Denkinger B, Sebring NG, McHugh T, Remaley AT et al. Inflammation and iron deficiency in the hypoferremia of obesity. Int J Obes (Lond) 2007; 31: 1412-9.
4. Menzie CM, Yanoff LB, Denkinger BI, McHugh T, Sebring NG, Calis KA et al. Obesity-related hypoferremia is not explained by differences in reported intake of heme and nonheme iron or intake of dietary factors that can affect iron absorption. J Am Diet Assoc 2008; 108: 145-8.
5. Müller-Riemenschneider F, Reinhold T, Berghöfer A, Willich SN. Health-economic burden of obesity in Europe. Eur J Epidemiol 2008; 23: 499-509.
6. Catalán V, Gómez-Ambrosi J, Ramirez B, Rotellar F, Pastor C, Silva C et al. Proinflammatory cytokines in obesity: impact of type 2 diabetes mellitus and gastric bypass. Obes Surg 2007; 17: 1464-74.
7. O'Rourke RW. Inflammation in obesity-related diseases. Surgery 2009; 145: 255-9.
8. Morínigo R, Casamitjana R, Delgado S, Lacy A, Deulofeu R, Conget I et al. Insulin resistance, inflammation, and the metabolic syndrome following Roux-en-Y gastric bypass surgery in severely obese subjects. Diabetes Care 2007; 30: 1906-8.
9. Puglisi MJ, Fernandez ML. Modulation of C-reactive protein, tumor necrosis factor-alpha, and adiponectin by diet, exercise, and weight loss. J Nutr 2008; 138: 2293-6.
10. Forsythe LK, Wallace JM, Livingstone MB. Obesity and inflammation: the effects of weight loss. Nutr Res Rev 2008; 21: 117-33.
11. Ocón Bretón J, Pérez Naranjo S, Gimeno Laborda S, Benito Ruesca P, García Hernández R. Eficacia y complicaciones de la cirugía bariátrica en tratamiento de la obesidad mórbida. Nutr Hosp 2005; 20: 409-14.
12. Cánovas B, Sastre J, Neblett A, López-Pardo R, Abad S, Moreno G, López J. Técnicas en cirugía bariátrica: experiencia en 78 casos. Nutr Hosp 2006; 21: 567-72.
13. Vázquez Prado A, Montalvá Orón EM, de Tursi Ríspoli LC. Valoración de la evolución de las comorbilidades de la obesidad mórbida tras el tratamiento quirúrgico mediante la técnica del cruce duodenal. Nutr Hosp 2007; 22: 596-601.
14. Tice JA, Karliner L, Walsh J, Petersen AJ, Feldman MD. Gastric banding or bypass? A systematic review comparing the two most popular bariatric procedures. Am J Med 2008; 121: 885-93.
15. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005; 352: 1011-23.
16. Muñoz M, Campos A, García-Erce JA, Ramírez G. Fisiopatología del metabolismo del hierro: implicaciones diagnósticas y terapéuticas. Nefrología 2005; 25: 9-19.
17. Chung B, Matak P, McKie AT, Sharp P. Leptin increases the expression of the iron regulatory hormone hepcidin in HuH7 human hepatoma cells. J Nutr 2007; 137: 2366-70.
18. Bekri S, Gual P, Anty R, Luciani N, Dahman M, Ramesh B et al. Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH. Gastroenterology 2006; 131: 788-96.
19. De Maria EJ. Bariatric Surgery for Morbid Obesity. N Engl J Med 2007; 356: 2176-83.
20. Karenkov M, Saverland S. Clinical uptate: bariatric surgery. Lancet 2007; 370 (9604): 1988-90.
21. Buchwald H, Avidor Y, Braunwald E et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004; 292: 1724-37.
22. Carvajal-Balaguera J, Martín García-Almenta M, Oliart Delgado S, Camuñas-Segovia J, Peña-Gamarra L, Fernández IP et al. Bypass gástrico en el tratamiento de la obesidad mórbida y la superobesidad: estudio comparativo. Nutr Hosp 2007; 22 (5): 607-11.
23. Maggard MA, Shugarman LR, Suttorp M, Maglione M, Sugerman HJ, Livingston EH et al. Meta-analysis: surgical treatment of obesity. Ann Intern Med 2005; 142: 547-59.
24. Sjöström L, Narbro K, Sjöström CD, Karason K, Larsson B, Wedel H et al. Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects. N Engl J Med 2007; 357: 741-52.
25. Colquitt JL, Picot J, Loveman E, Clegg AJ. Surgery for obesity. Cochrane Database Syst Rev 2009: CD003641.
26. Aufreiter S, Gregory JF, Pfeiffer CM, Fazili Z, Kim Y-I, Marcon N et al. Folate is absorbed across the colon of adults: evidence from fecal infusion of 13C-labeled [6S]-5-formyltetrahydrofolic acid. Am J Clin Nutr 2009; 90: 116-113.
27. Guralnik JM, Eisenstaedt RS, Ferrucci L, Klein HG, Woodman RC. The prevalence of anemia in persons aged 65 and older in the United States: evidence for a high rate of unexplained anemia. Blood 2004; 104: 2263-8.
28. Muñoz M, Ruiz Márquez MJ, García Segovia S, García Almeida JM, Campos A, Ramírez G. Prevalencia de anemia y deficiencias de hematínicos en pacientes sometidos a cirugía bariátrica en un hospital universitario. Anemia 2008; 1: 14-21 (a).
29. Shander A, Knight K, Thurer R, Adamson J, Spence R. Prevalence and Outcomes of Anemia in Surgery: A Systematic Review of the Literature. Am J Med 2004; 116: 58S-69S.
30. Beris P, Muñoz M, García-Erce JA, Thomas D, Maniatis A, Van der Linden P. Perioperative anaemia management: consensus statement on the role of intravenous iron. Br J Anaesth 2008; 100: 599-604.
31. Cook JD. Diagnosis and management of iron-deficiency anaemia. Best Pract Res Clin Haematol 2005; 18: 319-32.
32. Theurl I, Aigner E, Theurl M, Nairz M, Seifert M, Schroll A et al. Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications. Blood 2009 Mar 17. [Epub ahead of print].
33. Andrews NC. Forging a field: the golden age of iron biology. Blood 2008; 112: 219-30.
34. Poitou Bernert C, Ciangura C, Coupaye M, Czernichow S, Bouillot JL, Basdevant A. Nutritional deficiency after gastric bypass: diagnosis, prevention and treatment. Diabetes Metab 2007; 33: 13-24.
35. Thomas C, Thomas L. Biochemical markers and hematologic indices in the diagnosis of functional iron deficiency. Clin Chem 2002: 48: 1066-76.
36. Martínez-Valls JF, Civera Andrés M. Déficits nutricionales tras la cirugía bariátrica. Rev Esp Obes 2007; 5 (1): 19-26.
37. Ferrucci L, Guralnik JM, Bandinelli S, Semba RD, Lauretani F, Corsi A et al. Unexplained anaemia in older persons is characterised by low erythropoietin and low levels of pro-inflammatory markers. Br J Haematol 2007; 136: 849-55.
38. Skroubis G, Sakellaropoulos G, Pouggouras K, Mead N, Nikiforidis G, Kalfarentzos F. Comparison of nutritional deficiencies after Roux-en-Y gastric bypass and after biliopancreatic diversion with Roux-en-Y gastric bypass. Obes Surg 2002; 12: 551-8.
39. Coupaye M, Puchaux K, Bogard C, Msika S, Jouet P, Clerici C, Larger E, Ledoux S. Nutritional consequences of adjustable gastric banding and gastric bypass: a 1-year prospective study. Obes Surg 2009; 19: 56-65.
40. Flancbaum L, Belsley S, Drake V, Colarusso T, Tayler E. Preoperative nutritional status of patients undergoing Roux-en-Y gastric bypass for morbid obesity. J Gastrointest Surg 2006; 10: 1033-7.
41. Ernst B, Thurnheer M, Schmid SM, Schultes B. Evidence for the necessity to systematically assess micronutrient status prior to bariatric surgery. Obes Surg 2009; 19: 66-73.
42. Toh SY, Zarshenas N, Jorgensen J. Prevalence of nutrient deficiencies in bariatric patients. Nutrition 2009 [Epub ahead of print].
43. Beutler E, Waalen J. The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration? Blood 2006; 107: 1747-50.
44. Brolin RE, Gorman JH, Gorman RC, Petschenik AJ, Bradley LJ, Kenler HA et al. Are vitamin B12 and folate deficiency clinically important after roux-en-Y gastric bypass? J Gastrointest Surg 1998; 2: 436-42.
45. Vargas-Ruiz AG, Hernández-Rivera G, Herrera MF. Prevalence of iron, folate, and vitamin B12 deficiency anemia after laparoscopic Roux-en-Y gastric bypass. Obes Surg 2008; 18: 288-93.
46. Vázquez Prado A, García Fadrique A, Montalvá Orón EM. Evolución de los parámetros sanguíneos tras cirugía de la obesidad mórbida mediante la técnica del cruce duodenal. Nutr Hosp 2008; 23: 449-57.
47. Gasteyger C, Suter M, Gaillard RC, Giusti V. Nutritional deficiencies after Roux-en-Y gastric bypass for morbid obesity often cannot be prevented by standard multivitamin supplementation. Am J Clin Nutr 2008; 87: 1128-33.
48. Gracia JA, Martínez M, Elia M, Aguilella V, Royo P, Jiménez A, Bielsa MA, Arribas D. Obesity surgery results depending on technique performed: long-term outcome. Obes Surg 2009; 19: 432-8.
49. Walters GO, Miller FM, Worwood M. Serum ferritin concentration and iron stores in normal subjects. J Clin Pathol 1973; 26: 770-772.
50. Rhode BM, Shustik C, Christou NV et al. Iron absorption and therapy after gastric bypass. Obes Surg 1999; 9: 17-21.
51. Gisbert JP, Gomollón F. Common misconceptions in the diagnosis and management of anemia in inflammatory bowel disease. Am J Gastroenterol 2008; 103: 1299-307.
52. Bisbe E, Castillo J, Saez M, Santiveri X, Nomen N, Muñoz M. Prevalence of preoperative anemia and hematinic deficiencies in patients scheduled for elective major orthopedic surgery. TATM 2008; 10: 166-73.
53. Crichton RR, Danielsson BG, Geisser P. Iron therapy with special emphasis on intravenous administration. UNI-Med Verlag AG, Bremen, 2008.
54. Muñoz M, Breymann C, García-Erce JA, Gómez- Ramírez S, Comin J, Bisbe E. Efficacy and safety of intravenous iron therapy as an alternative/adjunct to allogeneic blood transfusion. Vox Sang 2008; 94: 172-83.
55. Briges KR. Prevention of iron deficiency in surgical women. In: Transfusion Medicine and Alternatives to Blood Transfusion. R & J Éditions Médicales, Paris, 2000: 251-8.
56. Goodnough LT, Skikne B, Brugnara C. Erythropoietin, iron, and erythropoiesis. Blood 2000; 96: 823-33.
57. Muñoz M, García-Erce JA, Díez-Lobo AI, Campos A, Sebastianes C, Bisbe E. Utilidad de la administración de hierro sacarosa intravenoso para la corrección de la anemia preoperatoria en pacientes programados para cirugía mayor. Med Clin (Barc) 2009; 132: 303-6.
58. Andrews CM, Lane DW, Bradley JG. Iron pre-load for major joint replacement. Transfus Med 1997; 7: 281-6.
59. Cuenca J, García-Erce JA, Martínez F, Cardona R, Pérez-Serrano L, Muñoz M. Preoperative haematinics and transfusion protocol reduce the need for transfusion after total knee replacement. Inter J Surg 2007; 5: 89-94.
60. García-Erce JA, Cuenca J, Martínez F, Cardona R, Pérez-Serrano L, Muñoz M: Perioperative intravenous iron may transfusion requirements and hasten the recovery from postoperative anaemia after knee replacement surgery. Transf Med 2006; 16: 335-41.
61. Vychytil A, Haag-Weber M. Iron status and iron supplementation in peritoneal dialysis patients. Kidney Int 1999; 55: S71-S78.
62. Feldman HI, Joffe M, Robinson B, Knauss J, Cizman B, Guo W et al. Administration of parenteral iron and mortality among hemodialysis patients. J Am Soc Nephrol 2004; 15: 1623-32.
63. Harju E. Empty iron stores as a significant risk factor in abdominal surgery. J Parenter Enteral Nutr 1988; 12: 282-5.
64. García Erce JA, Izuel Rami M, Cuenca Espiérrez Jorge J, Rabanaque Hernández MJ. [Allogeneic blood transfusion, nosocomial infection and venous thrombosis: Protective role of intravenous iron.] Med Clin (Barc) 2009 Apr 14 [Epub ahead of print].
65. Rutledge R, Walsh TR. Continued excellent results with the mini-gastric bypass: six-year study in 2,410 patients. Obes Surg 2005; 15: 1304-8.
66. Csendes A, Burdiles P, Papapietro K, Diaz JC, Maluenda F, Burgos A, Rojas J. Results of gastric bypass plus resection of the distal excluded gastric segment in patients with morbid obesity. J Gastrointest Surg 2005; 9: 121-31.
67. Salinas HM, Santiago E, García W, Ferro Q, Antor M. Silastic ring vertical gastric bypass: cohort study with 83% rate of 5-year follow-up. Surg Obes Relat Dis 2008 [Epub ahead of print].
68. Love AL, Billet HH. Obesity, bariatric surgery, and iron deficiency: True, true, true and related. Am J Hematol 2008; 83: 403-9.
69. Marinella MA. Anemia following Roux-en-Y surgery for morbid obesity: a review. South Med J 2008; 101: 1024-31.
70. Von Drygalski A, Andris DA. Anemia after bariatric surgery: more than just iron deficiency. Nutr Clin Pract 2009; 24: 217-26.
71. Alvarez-Leite JI. Nutrient deficiencies secondary to bariatric surgery. Curr Opin Clin Nutr Metab Care 2004; 7: 569-75.
72. Malinowski SS. Nutritional and metabolic complications of bariatric surgery. Am J Med Sci 2006; 331: 219-25.
73. Gredilla E, Gimeno M, Canser E, Martínez B, Pérez-Ferrer A, Gilsanz F. Tratamiento de la anemia en el postparto y en el postoperatorio inmediato de cirugía ginecológica, con hierro intravenoso. Rev Esp Anestesiol Reanim 2006; 53: 208-13.
74. Schroder O, Mickisck O, Seidler U, de Weerth A, Dignass AU, Herfath H Reinshagen M, Schreiber S, Junge U, Schrott M, Stein J. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease- A randomized, controlled, openlabel, multicenter study. Am J Gastroenterol 2005; 100: 2503-2509. PMID: 16279906.
75. Kulnigg S, Stoinov S, Simanenkov V, Dudar LV, Karnafel W, Garcia LC, Sambuelli AM, D'Haens G, Gasche C. A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial. Am J Gastroenterol 2008; 103: 1182-92. PMID: 18371137.
76. Lindgren S, Wikman O, Befrits R, Blom H, Eriksson A, Granno C, Ung KA, Hjortswang H, Lindgren A, Unge P. Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: A randomized, controlled, evaluator-blind, multicentre study. Scand J Gastroenterol 2009 [Epub ahead of print] PMID: 19330567.
77. Mizón C, Ruz M, Csendes A, Carrasco F, Rebolledo A, Codoceo J et al. Persistent anemia after Roux-en-Y gastric bypass. Nutrition 2007; 23: 277-80.
78. Varma S, Baz W, Badine E, Nakhl F, McMullen H, Nicastro J et al. Need for parenteral iron therapy after bariatric surgery. Surg Obes Relat Dis 2008; 4: 715-9.
79. Scrimshaw NS, Sangiovanni JP. Synergism of nutrition, infection, and immunity: an overview. Am J Clin Nutr 1997; 66: 464S-477S.
80. Oppenheimer SJ. Iron and its relation to immunity and infectious disease. J Nutr 2001; 131: 616S-635S.
81. Bellamy MC, Gednaey JA. Unrecognised iron deficiency in critical illness. Lancet 1998; 352: 1903.
82. Van Iperen CE, Gaillard CA, Kraaijenhagen RJ et al. Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients. Crit Care Med 2000; 28: 2773-8.
83. Rubio MA, Martínez C, Vidal O, Larrad A, Salas-Salvadó J, Pujol J et al. Documento de consenso sobre cirugía bariátrica. Rev Esp Obes 2004; 4: 223-249.
84. Fried M, Hainer V, Basdevant A et al. Inter-disciplinary European guidelines on surgery of severe obesity. Int J Obesity 2007; 31: 569-577.
85. Mechanick JI, Kushner RF, Sugerman HJ, Gonzalez-Campoy JM, Collazo-Clavell ML, Guven S, et al. Executive summary of the Recommendations of the American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery Medical Guidelines for clinical practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. Endocr Pract 2008; 14: 318-336.